Market News & Trends
Octapharma Adopts Genedata Bioprocess to Develop Next-Generation Bio-Manufacturing Processes
Genedata recently announced that Octapharma has adopted the Genedata Bioprocess platform to support the development and manufacturing of therapeutic proteins addressing severe diseases in the…
Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-Focused Emerald Organic Products
Amarantus will receive Emerald Preferred Stock to be valued at a minimum of $100 million in 2022, and up to double digit royalties (in addition to pass-through royalties and milestones) in exchange for worldwide, exclusive development and commercial rights to….
Sustainability is Everyone’s Obligation
Acting with social responsibility is far more than the very important role of environment protection, it also includes overall sustainability and acting in a manner that…..
Nanotechnology World Association is Launched by Solid Group of Founding Members
This new global nanotechnology association will bolster the necessary links between research and industries and facilitate the adoption and commercialization of…….
Driving Improvements in Clinical Trial Results Sharing
The world’s leading medical journals now require authors to disclose whether or not they’ll be sharing clinical trial results, a public declaration that may nudge…
CPI Accelerates Gene Therapy Development With Robust Purification System
CPI recently announced the success of its CRD IUK project to develop a scalable, cost-effective purification process for adeno-associated viruses (AAVs), in partnership with Cobra…
Foamix Receives FDA Approval for Topical Treatment
Foamix Pharmaceuticals Ltd. recently announced the US FDA has approved its novel AMZEEQ (minocycline) topical foam, 4%. AMZEEQ, formerly known as FMX101, is indicated for…
Theralase Granted European Patent for Anti-Cancer Photo Dynamic Compounds
Theralase Technologies Inc. recently announced the company has been granted a European Patent for their anti-cancer PDCs, which will issue in due course. The patent,…
Genedata & Merck Co-Develop Digital Platform
Genedata recently announced the successful completion of a multi-year software development project in close collaboration with Merck, a leading science and technology company. Fulfilling Merck’s…
BD Launches Two-Step Disposable Autoinjector
BD (Becton, Dickinson and Company) recently announced the launch of the BD Intevia 1 mL two-step disposable autoinjector, a robust platform device combining autoinjector and…
CombiGene Signs Agreement With Cobra Biologics
CombiGene AB recently signed an agreement with the Anglo-Swedish Contract Development and Manufacturing Organisation (CDMO) Cobra Biologics (Cobra) for production of candidate drug CG01. The…
Adaptate Biotherapeutics Formed to Develop Antibody-Based Therapies That Modulate Gamma Delta T-Cells
GammaDelta Therapeutics, a company focussed on harnessing the unique properties of gamma delta T-cells to develop transformational immunotherapies, recently announced the formation of a spin-out…
Yourway Mitigates Uncertainty of Brexit for Clinical Trials In Europe
Yourway, the only truly integrated premium courier and clinical packager in the industry, announced its establishment of a new location within the European Union providing…
Novavax Initiates Pivotal Phase 3 Clinical Trial
Novavax, Inc. recently announced the initiation of a pivotal Phase 3 clinical trial for NanoFlu, its recombinant quadrivalent seasonal influenza vaccine candidate, in adults aged…
Orgenesis Announces Co-Development Agreement With Accellix
Orgenesis Inc recently announced it has entered into a co-development agreement with Accellix, Inc. The agreement will enable Orgenesis to integrate Accellix’s proprietary optic system, cartridges, reagents,…
An End to Alzheimer’s? New Drugs Fight Memory Loss
Researchers in Toronto have developed an experimental drug that appears to renew the underlying brain impairments causing memory loss, fuelling hopes that a treatment for…
Patient-Derived Tumor Organoid Drug Development Platform Launched
Crown Bioscience recently announced the launch of a new tumor organoid drug development platform with the potential to significantly improve the……
White Paper: Control of Beta-Glucans & Endotoxin in High Purity Sucrose for Biopharmaceutical Applications
This white paper discusses a Quality by Design (QbD) scenario that allows end users to rationally select the well characterized excipients during biopharmaceutical development and develop a control strategy for biologic drug products.
White Paper: High Purity Low Endotoxin Arginine: Applications in Biopharmaceutical Processing & Biotherapeutic Stabilization
This white paper discusses arginine, also known as L-arginine (symbol Arg or R), a basic amino acid widely used in biopharmaceutical processing and stabilization of biotherapeutics.
Credence MedSystems Awarded Gates Foundation Grant to Develop Dual Chamber Drug Delivery Device
Credence MedSystems, an innovator in injectable drug delivery technology for the biopharmaceutical industry, recently announced it has been awarded a grant from the Bill & Melinda Gates Foundation to support the…..
